“…The endoscopic approach is feasible mainly for gastrointestinal (intraluminal) bleeding; reoperation is traditionally reserved for intra-abdominal (extraluminal) bleeding, but carries substantial morbidity and mortality for late bleeding [3, 10]. Intravascular intervention, such as transarterial embolization or the placement of covered stents to occlude the orifice of the bleeding vessel, is a minimally invasive procedure and can be considered as a good alternative to reoperation [2,3, 5,9,10,11,12,13,14,15,16,17,18,19,20]. Therefore, determining the risk factors for post-pancreaticoduodenectomy bleeding and accumulating treatment experience is of utmost importance for pancreatic surgeons.…”